Medicine Institute, Sheikh Khalifa Medical City, Al Karamah Street, P.O. Box 51900, Abu Dhabi, UAE.
Lung. 2012 Jun;190(3):347-51. doi: 10.1007/s00408-011-9369-1. Epub 2012 Jan 14.
Pneumothorax from bronchopleural or alveolo-pleural fistulae can be complicated by prolonged air leak (AL). This can occur in a variety of clinical settings. Examples include structural lung disease, such as bronchiectasis, and cavitary lung disorders. Prolonged AL is associated with prolonged hospital stay, atelectasis, pneumonia, and thromboembolic disease. Endobronchial valves (EBVs) have been recently introduced to manage such situations. The global experience in this novel therapeutic modality is still evolving. We report our preliminary experience with managing persistent AL treated successfully with EBVs and review the current literature on this subject. Our experience shows that EBVs are an effective tool for the management of prolonged AL from persistent bronchopleural or alveolo-pleural fistulae. It is a minimally invasive procedure recommended as an option, particularly in patients not fit for surgical repair.
支气管胸膜或肺泡胸膜瘘引起的气胸可并发持续性空气漏（AL）。这种情况可能发生在各种临床情况下。例如，结构性肺病，如支气管扩张症和空洞性肺疾病。持续性 AL 与住院时间延长、肺不张、肺炎和血栓栓塞性疾病有关。支气管内瓣膜（EBV）最近已被引入用于此类情况。这种新治疗方式的全球经验仍在不断发展。我们报告了使用 EBV 成功治疗持续性 AL 的初步经验，并回顾了该主题的当前文献。我们的经验表明，EBV 是治疗持续性支气管胸膜或肺泡胸膜瘘引起的持续性 AL 的有效工具。这是一种微创程序，建议作为一种选择，特别是对于不适合手术修复的患者。
